Skip to content
10-Q

Quarterly Report

Ocular Therapeutix, Inc. OCUL

0001558370-25-010177

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 174M sh
Shares Diluted Q2 2025 · Jun 30, 2025 172.59M sh
Shares Diluted Q2 2025 · Jun 30, 2025 171M sh
Shares Diluted Q2 2025 · Jun 30, 2024 165.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 148.92M sh
Capex Q2 2025 · Jun 30, 2025 $3.18M
Capex Q2 2025 · Jun 30, 2024 $997K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$99.91M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$58.69M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $391.13M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $392.1M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $459.69M
Stockholders Equity Q2 2025 · Jun 30, 2025 $305.92M
Stockholders Equity Q2 2025 · Mar 31, 2025 $265.93M
Stockholders Equity Q2 2025 · Dec 31, 2024 $315.34M
Stockholders Equity Q2 2025 · Jun 30, 2024 $377.7M
Stockholders Equity Q2 2025 · Mar 31, 2024 $407.98M
Stockholders Equity Q2 2025 · Dec 31, 2023 $91.13M
Current Liabilities Q2 2025 · Jun 30, 2025 $42.93M
Current Liabilities Q2 2025 · Dec 31, 2024 $41.35M
Total Liabilities Q2 2025 · Jun 30, 2025 $145.42M
Total Liabilities Q2 2025 · Dec 31, 2024 $142.59M
Current Assets Q2 2025 · Jun 30, 2025 $433.38M
Current Assets Q2 2025 · Dec 31, 2024 $440.99M
Total Assets Q2 2025 · Jun 30, 2025 $451.33M
Total Assets Q2 2025 · Dec 31, 2024 $457.94M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.39
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.77
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.73
Eps Basic Q2 2025 · Jun 30, 2025 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$0.77
Eps Basic Q2 2025 · Jun 30, 2024 −$0.26
Eps Basic Q2 2025 · Jun 30, 2024 −$0.73
Sga Expense Q2 2025 · Jun 30, 2025 $14.35M
Sga Expense Q2 2025 · Jun 30, 2025 $30.69M
Sga Expense Q2 2025 · Jun 30, 2024 $19.67M
Sga Expense Q2 2025 · Jun 30, 2024 $33.82M
Rd Expense Q2 2025 · Jun 30, 2025 $51.08M
Rd Expense Q2 2025 · Jun 30, 2025 $93.94M
Rd Expense Q2 2025 · Jun 30, 2024 $28.86M
Rd Expense Q2 2025 · Jun 30, 2024 $49.59M
Net Income Q2 2025 · Jun 30, 2025 −$67.81M
Net Income Q2 2025 · Jun 30, 2025 −$131.87M
Net Income Q2 2025 · Mar 31, 2025 −$64.05M
Net Income Q2 2025 · Jun 30, 2024 −$43.78M
Net Income Q2 2025 · Jun 30, 2024 −$108.63M
Net Income Q2 2025 · Mar 31, 2024 −$64.85M
Operating Income Q2 2025 · Jun 30, 2025 −$67.64M
Operating Income Q2 2025 · Jun 30, 2025 −$131.56M
Operating Income Q2 2025 · Jun 30, 2024 −$43.59M
Operating Income Q2 2025 · Jun 30, 2024 −$75.21M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.94M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.21M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.51M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.84M
Revenue Q2 2025 · Jun 30, 2025 $13.46M
Revenue Q2 2025 · Jun 30, 2025 $24.16M
Revenue Q2 2025 · Jun 30, 2024 $16.44M
Revenue Q2 2025 · Jun 30, 2024 $31.22M